Christine I Chen

8PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyNeurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

|Mar 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.

Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz

|Mar 03, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Inna Y Gong, Meenakshi Jeeva, Katrina Hueniken

|Jan 15, 2026
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal Impairment.

Rintu Sharma, Eshetu G Atenafu, Esther Masih-Khan

|Jun 09, 2025
Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma.

Barry Paul, Jiri Minarik, Francesca Cottini

|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities.

Ashish Patel, Esther Masih-Khan, Adam Smith

Pageof 2

Frequent Collaborators

2 joint publications

Esther Masih-Khan

2 joint publications

Rintu Sharma

1 joint publications

Cristina Gasparetto

1 joint publications

Anca Prica